| 生物活性 | |||
|---|---|---|---|
| 描述 | B-Raf IN 1 demonstrates potent anti-cancer activity with low micromolar IC50 values against WM 266-4 and HT29 cell lines. This suggests its potential utility in targeting cancers with B-Raf mutations or dependencies[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
1.94mL 0.39mL 0.19mL |
9.70mL 1.94mL 0.97mL |
19.40mL 3.88mL 1.94mL |
| 参考文献 |
|---|